Clinical Trials List
Protocol NumberM20-371
Completed
2022-02-01 - 2023-09-21
Phase II
Recruiting3
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 翁孟慈 無
- Tiffany Ting-Fang Shih 無
- 謝銘鈞 無
- 施怡倫 無
- 吳嘉峯 無
- YEN-HSUAN NI 無
- 吳嘉峰 未分科
- CHIEN-CHIH TUNG 無
- Huey-Ling Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Lung Feng 無
- 吳宜樺 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳家昌 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
265 participants
